In vitro activity of the new glycopeptide LY264826 versus vancomycin against clinical isolates of enterococci.

作者信息

Watanakunakorn C

机构信息

Department of Internal Medicine, St. Elizabeth Hospital Medical Center, Youngstown, Ohio 44501.

出版信息

Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):982-3. doi: 10.1007/BF02005460.

DOI:10.1007/BF02005460

PMID:1794373

Abstract

摘要

相似文献

In vitro activity of the new glycopeptide LY264826 versus vancomycin against clinical isolates of enterococci.

Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):982-3. doi: 10.1007/BF02005460.

Comparison of LY264826-gentamicin with vancomycin-gentamicin against enterococci from blood cultures.

J Antimicrob Chemother. 1992 Mar;29(3):303-6. doi: 10.1093/jac/29.3.303.

Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.

Antimicrob Agents Chemother. 1995 Nov;39(11):2585-7. doi: 10.1128/AAC.39.11.2585.

The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.

Adv Exp Med Biol. 1997;418:483-5. doi: 10.1007/978-1-4899-1825-3_115.

Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.

Clin Infect Dis. 1998 Aug;27 Suppl 1:S84-6. doi: 10.1086/514907.

Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.

Acta Univ Palacki Olomuc Fac Med. 1999;142:69-71.

Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.

J Antimicrob Chemother. 1997 Sep;40(3):423-5. doi: 10.1093/jac/40.3.423.

Hybrid glycopeptide antibiotics.

J Am Chem Soc. 2001 Dec 19;123(50):12722-3. doi: 10.1021/ja0166693.

The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.

Chemotherapy. 1996 Jul-Aug;42(4):235-9. doi: 10.1159/000239449.

Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.

J Antimicrob Chemother. 2016 Jan;71(1):152-5. doi: 10.1093/jac/dkv302. Epub 2015 Oct 16.

本文引用的文献

An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Antibiot Chemother (Northfield). 1959 May;9(5):307-11.

In vitro activity of LY 264826 compared with that of vancomycin against 100 clinical isolates each of methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Antimicrob Agents Chemother. 1990 Oct;34(10):2007-8. doi: 10.1128/AAC.34.10.2007.

In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.

Antimicrob Agents Chemother. 1990 Nov;34(11):2137-41. doi: 10.1128/AAC.34.11.2137.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验